69 Health Tech Startups in Switzerland to Watch in 2024
How do we build this list?
Tracking:
Last update to the database: March 25, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Cardiac ablation system developer for treating cardiac arrhythmias. |
$58M · Series B | Advent Life Sciences, Gilde Healthcare, Earlybird Venture Capital | 1 to 10 | Health Tech | Lausanne, Switzerland | •••••••••••@argamedtech.com | ||
Viral vector-based cancer vaccines developer. |
$82M · Series C | Bpifrance, 5AM Ventures, Abingworth | 1 to 10 | Health Tech, Biotech | B2C | Basel, Switzerland | •••••••••••@nouscom.com | |
AI-powered hypertension management platform. |
$30M · Series A | Khosla Ventures, Molten Ventures, Translink Capital | 51 to 100 | Health Tech, AI | B2C, SaaS | Bern, Switzerland | •••••••••••@aktiia.com | |
Antibody discovery and human immune repertoire analysis platform. |
$27M · Series C | Vesalius Biocapital Partners, Adjuvant Capital, Swisscanto Private Equity | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@memo-therapeutics.com | |
Small molecule mitophagy inducers developer. |
$20M · Series A | ND Capital | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@vandria.com | ||
Clinical-stage central nervous system (CNS) technology. |
$110M · Series B | Sofinnova Partners, Forbion Capital Partners, BioMedPartners | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@noemapharma.com | |
Neuro-interventional products developer for stroke and aneurysms. |
$6M · Series A | Nest Collective Foundation, Wyss Center, Verve Ventures | 1 to 10 | Health Tech, Manufacturing | B2C | Lausanne, Switzerland | •••••••••••@artiria-medical.com | |
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat and rehab patients. |
$125M | Hambro Perks Ltd. | 101 to 250 | Health Tech, AR / VR, Biotech, Deep Tech, Business Intelligence | B2B | Lausanne, Switzerland | •••••••••••@mindmaze.com | |
AI for early cancer detection. |
$25M · Series C | Xlife Sciences AG | 1 to 10 | Health Tech, AI | Zug, Switzerland | •••••••••••@4dlifetec.com | ||
Gene therapy research to tackle genetic diseases. |
$59M · Series A | Gimv | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@anjarium.com | |
Intelligent healthcare warning systems. |
$10M · Series A | UBS, Zürcher Kantonal Bank | 1 to 10 | Health Tech, Business Intelligence | B2B | Bern, Switzerland | •••••••••••@qumea.com | |
Developer of small molecules to treat novel drug resistance pathways in cancer therapy. |
$20M · Series A | BioMedPartners, Altos Ventures, Redalpine | 1 to 10 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@tolremo.com | ||
Self-adjuvanting and multi-antigen vaccine technology platform. |
$3M · Series A | Novo A/S, Adjuvant Capital, Repair Impact Fund | 11 to 50 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@lmtbio.com | ||
B2B SaaS human motion analysis platform. |
$30M | Creandum, Atomico, Eurazeo | 1 to 10 | Health Tech, AI, Machine Learning | B2B, SaaS | Zürich, Switzerland | •••••••••••@vay.ai | |
Stair-climbing electric wheelchair manufacturer. |
$9M · Series A | RSBG Ventures | 51 to 100 | Health Tech, Manufacturing | B2C | Zürich, Switzerland | •••••••••••@scewo.com | |
Medical devices developer for spine specialist surgeons. |
$32M · Series B | Gimv, Ernst Gohner Stiftung | 101to 250 | Health Tech, Hardware | B2B | Geneva, Switzerland | •••••••••••@spineart.com | |
RNA sequencing and transcriptomics analysis platform. |
$3M · Seed | Novalis Biotechnology Incubation, TechU Ventures, Foundation for Technological Innovation (FIT) | 1 to 10 | Health Tech, Biotech | B2B | Lausanne, Switzerland | •••••••••••@alitheagenomics.com | |
Glycanengineering platform. |
$49M · Series A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@glycoera.com | |
Longevity health products maker. |
$9M · Series C | Nestlé Health Science, Business Opportunities for L'Oréal Development, L'Oreal | 11 to 50 | Health Tech, Manufacturing | B2C | Lausanne, Switzerland | •••••••••••@timelinenutrition.com | |
Next-generation laboratory equipment developers. |
$13M · Series A | imec.xpand, Swisscanto Private Equity | 1 to 10 | Health Tech, Hardware | Lausanne, Switzerland | •••••••••••@nagibio.ch | ||
Non-invasive treatment for heart arrhythmias. |
$15M · Series A | EIC Accelerator, Panakes Partners | 1 to 10 | Health Tech, Biotech | B2B | Geneva, Switzerland | •••••••••••@eba-med.com | |
Accurate monitoring and treatment platform for sleep bruxism and sleep apnea. |
$3M · Seed | Zürcher Kantonal Bank, Supermoon Capital, Creadd Ventures | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@aesyra.com | ||
Manufacturer of drugs to combat the effects of ageing. |
$10M · Series A | Prima Materia | 11 to 50 | Health Tech, Biotech | B2C | Lausanne, Switzerland | •••••••••••@epiterna.com | |
Neo Medical is a medtech company developing solutions to achieve a more Functional Fusion in spinal surgery. |
$10M | Swisscom Ventures | 11 to 50 | Health Tech, Hardware, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@neo-medical.com | |
Program to increase human lifespan. |
$5M · Seed | Maximon | 11 to 50 | Health Tech, Biotech | B2C | Zug, Switzerland | •••••••••••@biolytica.com | |
Nanolive has developed a disruptive proprietary technology. |
$20M | Swisscom Ventures | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing, Business Intelligence | B2B, SaaS | Lausanne, Switzerland | •••••••••••@nanolive.ch | |
Home-test kit to perform blood tests. |
$10M · Series B | Speedinvest, Walter Ventures, Astor Perkins | 11 to 50 | Health Tech, Hardware, Manufacturing | B2C | Zürich, Switzerland | •••••••••••@bloomdiagnostics.com | |
Microcaps develops a novel technology that enables the scalable production of precise microcapsules and microparticles. |
$5M · Seed | Helvetica Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@microcaps.ch | |
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies. |
$15M · Seed | Novo A/S, Pureos Bioventures | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Basel, Switzerland | •••••••••••@engimmune.com | |
Clinically tested, patent-protected dietary therapy for migraines. |
$4M · Seed | Healthspan Capital, R42 Group | 1 to 10 | Health Tech, Foodtech | B2C | Basel, Switzerland | •••••••••••@keto.swiss | |
Immunotherapy platform for cancer. |
$330k · Pre Seed | Lightspeed Venture Partners, BioMedPartners, Gimv | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@immunostherapeutics.com | |
True precision medicine through single-cell science |
$1M · Series A | Verve Ventures, Swisscom Ventures | 11 to 50 | Health Tech, AI, Biotech | B2B | Basel, Switzerland | •••••••••••@scailyte.com | |
Mister Loo designs, constructs, and manages public toilet facilities through a tech-enabled service platform |
$5M | responsAbility | 1 to 10 | Health Tech, Proptech & Real Estate, Service Industry | B2B | Zürich, Switzerland | •••••••••••@misterloo.com | |
PeakData is a software platform to identify and analyze key opinion leaders in your therapeutic area. |
$12M | AlbionVC, Octopus Ventures | 11 to 50 | Health Tech, Media and Entertainement, Business Intelligence | B2B, Marketplace | Zug, Switzerland | •••••••••••@peakdata.com | |
DistalMotion develops medical devices that are used to perform minimal-invasive surgeries. |
$90M · Series E | 1 to 10 | Health Tech, Deep Tech, Robotics, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@distalmotion.com | ||
Pharvaris is a clinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients. |
$80M · Series C | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Zug, Switzerland | •••••••••••@pharvaris.com | ||
BC Platforms is a data and technology company providing tools to advance the development of personalized medicine and precision medicine. |
$20M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Zürich, Switzerland | •••••••••••@bcplatforms.com | ||
Qnami develops quantum sensing technologies designed for nanoscale imaging. |
$2M · Seed | Quantonation, High-Tech Gründerfonds, Verve Ventures | 11 to 50 | Health Tech, Hardware, Biotech, Navigation and Mapping, Manufacturing | B2B | Basel, Switzerland | •••••••••••@qnami.ch | |
Developer of an antibody-drug conjugates (ADCs). |
$110k · Pre Seed | btov Partners, Pureos Bioventures, Redalpine | 1 to 10 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@ararisbiotech.com | |
CREAL develops near-eye light-field display bringing true optical depth and better immersion into virtual and mixed reality. |
$4M | Verve Ventures, Swisscom Ventures, DAA Capital Partners | 11 to 50 | Health Tech, AR / VR, Manufacturing | B2B, SaaS | Lausanne, Switzerland | •••••••••••@creal.com | |
Developer of oral therapeutics to treat complex autoimmune diseases. |
$3M · Seed | Forty51 Ventures | 1 to 10 | Health Tech, Pharma | Basel, Switzerland | •••••••••••@mystheratx.com | ||
Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders. |
$50M · Series A | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Basel, Switzerland | •••••••••••@cimeio.com | ||
Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics. |
$30M · Series A | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Basel, Switzerland | •••••••••••@vectorbiopharma.com | ||
Planted is a food processing company that specializes in plant-based meals. |
$18M · Series A | 51 to 100 | Health Tech, Foodtech | Zürich, Switzerland | •••••••••••@eatplanted.com | |||
Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies. |
$25M · Series A | 1 to 10 | Health Tech, Fintech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@rejuveron.com | ||
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. |
$26M · Series C | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Basel, Switzerland | •••••••••••@t3pharma.com | ||
Fertility-tracking bracelet maker. |
$110k · Pre Seed | Khosla Ventures, Swisscom Ventures, Zürcher Kantonal Bank | 51 to 100 | Health Tech, Femtech | B2C | Zürich, Switzerland | •••••••••••@avawomen.com | |
Nanoleq enables the next generation of health-monitoring textiles. |
$1M | Verve Ventures, Capnamic Ventures | 11 to 50 | Health Tech, Hardware, Fashion, Manufacturing, Business Intelligence, Wearables | B2B, SaaS | Zürich, Switzerland | •••••••••••@nanoleq.com | |
Developer of fibrotic encapsulation solutions in implantable medical devices. |
$110k · Pre Seed | Verve Ventures, StartAngels Network, Venture Kick | 1 to 10 | Health Tech, Hardware | Zürich, Switzerland | •••••••••••@hylomorph-medical.com | ||
Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. |
$4M · Seed | High-Tech Gründerfonds, Verve Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Zürich, Switzerland | •••••••••••@invasight.com | |
Sleepiz is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment. |
$929k · Seed | Verve Ventures | 11 to 50 | Health Tech | B2B, SaaS | Zürich, Switzerland | •••••••••••@sleepiz.com | |
AI-powered navigation device maker for blind and visually impaired people. |
$1M · Seed | Serpentine Ventures | 1 to 10 | Health Tech, Navigation and Mapping | B2C | Lausanne, Switzerland | •••••••••••@biped.ai | |
Health tracking for preventive medicine. |
$6M · Seed | 11 to 50 | Health Tech | B2C | Zürich, Switzerland | •••••••••••@care.me | ||
Platform to monitor patient’s health and optimise care. |
$9M · Series A | 11 to 50 | Health Tech | B2C | Lausanne, Switzerland | •••••••••••@domo.health | ||
OnlineDoctor is an innovative Swiss-based platform that allows the user to diagnosed any skin problems quickly. |
$6M · Series A | 11 to 50 | Health Tech, Mobile | B2C | Saint Gallen, Switzerland | •••••••••••@onlinedoctor.ch | ||
Rheon focuses on the development of first-in-class glaucoma drainage devices. |
$6M | 1 to 10 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@rheonmedical.com | ||
Loop Medical develops an easy and painless blood collection technology making it accessible to all. |
$6M · Series A | 1 to 10 | Health Tech, Hardware, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@loop-medical.com | ||
Virometix is a privately held biotechnology company developing |
$8M · Series B | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@virometix.com | ||
Navignostics aims to identify the ideal treatment to each cancer patient’s disease. |
$7M | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma | Zürich, Switzerland | •••••••••••@navignostics.com | |||
Spine surgical robotic systems. |
$9M · Series A | 1 to 10 | Health Tech, Deep Tech, Robotics | Bern, Switzerland | •••••••••••@lemsurgical.com | |||
Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases. |
$16M · Series A | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Geneva, Switzerland | •••••••••••@chordtherapeutics.com | ||
Rqmicro develops a pathogen separation and detection technology that delivers accurate results in less than 2 hours |
$6M · Series B | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence | B2B | Zürich, Switzerland | •••••••••••@rqmicro.com | ||
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs. |
$6M · Seed | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@versameb.com | ||
PIPRA is developing a cutting-edge AI-based pre-surgical tool to assess patients’ risk of suffering from cognitive impairment after surgery. |
$1M · Pre Seed | Plug and Play Spain, Forward VC | 1 to 10 | Health Tech, Hardware | B2B, SaaS | Zürich, Switzerland | •••••••••••@pipra.ch | |
Molecule is a software platform used to accelerate innovation in the pharmaceutical industry. |
N/A | BACKED VC, Speedinvest, BoxGroup | 11 to 50 | Health Tech, Fintech, Crypto & web3, Biotech, Deep Tech, Pharma | B2B, Marketplace | Schaffhausen, Switzerland | •••••••••••@molecule.to | |
Automated visual inspection for pharma. |
$877k · Seed | Spicehaus Partners | 1 to 10 | Health Tech | Basel, Switzerland | •••••••••••@axom.tech | ||
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics. |
$125k · Pre Seed | Y Combinator, Wingman Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@adaptyvbio.com | |
We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening |
$166k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma, Manufacturing, ElderTech | B2B | Lausanne, Switzerland | •••••••••••@flowbone.com | |
Positrigo is a company dedicated to the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. |
$4M · Series A | 11 to 50 | Health Tech, Hardware, Manufacturing | B2B | Zürich, Switzerland | •••••••••••@positrigo.com |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.